Impax Asset Management Group »

ResMed shares owned by Impax Asset Management Group

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Impax Asset Management Group from 13F filings

Historical chart of Impax Asset Management Group investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Impax Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Impax Asset Management Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $932k 3.9k 240.87
2025-09-30 $1.1M 3.9k 273.73

More positions owned by Impax Asset Management Group

Linde Common Stock (LIN)
Microsoft Corp Common Stock (MSFT)
Xylem Common Stock (XYL)
NVIDIA Corp Common Stock (NVDA)
Hubbell Common Stock (HUBB)
Agilent Technologies Common Stock (A)
Pentair Common Stock (PNR)
Aptiv Common Stock (APTV)
Veralto Corp Common Stock (VLTO)
American Water Works Common Stock (AWK)
A O Smith Corp Common Stock (AOS)
IDEX Corp Common Stock (IEX)
Advanced Drainage Systems Common Stock (WMS)
eBay Common Stock (EBAY)
RenaissanceRe Holdings Common Stock (RNR)

View all positions for Impax Asset Management Group

Top funds holding ResMed

Vanguard Group
BlackRock
State Street Corporation
Bank of New York Mellon
Geode Capital Management
Invesco
Northern Trust
First Trust Advisors
Deutsche Bank Aktiengesellschaft
Charles Schwab Investment Management
Swedbank AB
Nordea Investment Management Ab
Norges Bank Investment Management
Legal & General Group
Dimensional Fund Advisors

View all funds holding ResMed